Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (311-320 of 655) with videos related to

Pageof 66
Sort By:
Analytical Biochemistry|February 6, 1998
Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassayA Sparreboom, W J Loos, J Verweij, et al.
Protist|February 8, 2011
Increased sampling reveals novel lineages of Entamoeba: consequences of genetic diversity and host specificity for taxonomy and molecular detectionC Rune Stensvold, Marianne Lebbad, Emma L Victory, et al.
Analytical Biochemistry|January 16, 1999
Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatographyP de Bruijn, J Verweij, W J Loos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative GroupA Ardizzoni, H Hansen, P Dombernowsky, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2009
Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopyL E S Bruijnesteijn van Coppenraet, J A Wallinga, G J H M Ruijs, et al.
British Journal of Cancer|January 1, 1997
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatinP H Hilkens, L C Pronk, J Verweij, et al.
American Journal of Clinical Oncology|August 24, 2000
Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic studyD Schrijvers, L Pronk, M Highley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatinP A van Liessum, C Seynaeve, P H de Mulder, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidneyJ Verweij, S Kerpel-Fronius, M Stuurman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupA Santoro, T Tursz, H Mouridsen, et al.
Pageof 66

Showing results (311-320 of 655) with videos related to

Sort By:
Pageof 66
Analytical Biochemistry|February 6, 1998
Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassayA Sparreboom, W J Loos, J Verweij, et al.
Protist|February 8, 2011
Increased sampling reveals novel lineages of Entamoeba: consequences of genetic diversity and host specificity for taxonomy and molecular detectionC Rune Stensvold, Marianne Lebbad, Emma L Victory, et al.
Analytical Biochemistry|January 16, 1999
Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatographyP de Bruijn, J Verweij, W J Loos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative GroupA Ardizzoni, H Hansen, P Dombernowsky, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 24, 2009
Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopyL E S Bruijnesteijn van Coppenraet, J A Wallinga, G J H M Ruijs, et al.
British Journal of Cancer|January 1, 1997
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatinP H Hilkens, L C Pronk, J Verweij, et al.
American Journal of Clinical Oncology|August 24, 2000
Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic studyD Schrijvers, L Pronk, M Highley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatinP A van Liessum, C Seynaeve, P H de Mulder, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidneyJ Verweij, S Kerpel-Fronius, M Stuurman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupA Santoro, T Tursz, H Mouridsen, et al.
Pageof 66